← Leaderboards
Wei Xu
University Of Wisconsin-Madison
$10,169,679
Attributed
$11,593,525
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2008–25$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,593,525 · 12
By mechanism
R01$7,750,285 · 5
T32$2,350,377 · 1
R21$951,647 · 3
R03$381,366 · 2
S10$159,850 · 1
Top collaborators
- Heather B Neuman5 shared
- Shaoqin - Gong2 shared
- Caroline Margaret Alexander1 shared
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Emery H. Bresnick$23,812,634
- Andrew Michael Baschnagel$1,031,492
- Lee Gravatt Wilke$2,208,644
- Lisa M Barroilhet$6,710,460
- C. David Page$9,399,195
Others in their field
Top investigators on “Cell Line”
- David Heimbrook · Leidos Biomedical Research, Inc.$236,973,333
- Dennis R. Burton · Scripps Research Institute$203,685,614
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$177,001,772
- John M Lachin · George Washington University$118,672,444
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- Fred M Gordin · Social And Scientific Systems, Inc.$82,802,056
Research focus
Cell LineIn VivoCellsMalignant Breast NeoplasmMediatingMolecularTumorGenetic TranscriptionResistanceComplexMethyltransferaseBreast Cancer CellGene ExpressionProteinsGenesEstrogen ReceptorsArginineCoactivator-Associated Arginine Methyltransferase 1MethylationHistone H3MutantPathway InteractionsEpigenetic ProcessKnock-Down
Grant awards (41)
UW Surgical Oncology Research Training Program (UW-SORT)$482,702
T32 · FY2025 · CA
Functions of BRD8 in HR+/HER2+ breast cancer$419,043
R01 · FY2025 · CA · contact PI
Ctr9 as a Predictive Biomarker for EZH2 Inhibitor Sensitivity$403,171
R01 · FY2025 · CA · contact PI
Protein arginine methylation in breast cancer$382,090
R01 · FY2025 · CA · contact PI
Mechanism and treatment of Wilms Tumors caused by CTR9 mutations$218,089
R21 · FY2025 · CA · contact PI
A New Strategy for Screening Effective Therapies for Metastatic Wilms Tumors$179,872
R21 · FY2025 · CA · contact PI
UW Surgical Oncology Research Training Program (UW-SORT)$469,876
T32 · FY2024 · CA
Functions of BRD8 in HR+/HER2+ breast cancer$398,093
R01 · FY2024 · CA · contact PI
Ctr9 as a Predictive Biomarker for EZH2 Inhibitor Sensitivity$382,472
R01 · FY2024 · CA · contact PI
Protein arginine methylation in breast cancer$382,090
R01 · FY2024 · CA · contact PI
A New Strategy for Screening Effective Therapies for Metastatic Wilms Tumors$216,221
R21 · FY2024 · CA · contact PI
UW Surgical Oncology Research Training Program (UW-SORT)$487,005
T32 · FY2023 · CA
Functions of BRD8 in HR+/HER2+ breast cancer$419,043
R01 · FY2023 · CA · contact PI
Ctr9 as a Predictive Biomarker for EZH2 Inhibitor Sensitivity$394,550
R01 · FY2023 · CA · contact PI
Protein Arginine Methylation in Breast Cancer$347,099
R01 · FY2023 · CA · contact PI
UW Surgical Oncology Research Training Program (UW-SORT)$480,409
T32 · FY2022 · CA
Ctr9 as a Predictive Biomarker for EZH2 Inhibitor Sensitivity$402,602
R01 · FY2022 · CA · contact PI
Protein Arginine Methylation in Breast Cancer$362,474
R01 · FY2022 · CA · contact PI
UW Surgical Oncology Research Training Program (UW-SORT)$430,385
T32 · FY2021 · CA
Protein Arginine Methylation in Breast Cancer$354,527
R01 · FY2021 · CA · contact PI
Interactive effects of physical activity and neighborhood air pollution on risk of incident Alzheimer's disease and related dementias$187,538
R03 · FY2021 · AG · contact PI
Protein Arginine Methylation in Chemotherapy Resistance$160,001
R01 · FY2021 · CA · contact PI
Interactive effects of physical activity and neighborhood air pollution on risk of incident Alzheimer's disease and related dementias$119,949
R03 · FY2021 · AG · contact PI
Protein Arginine Methylation in Breast Cancer$353,959
R01 · FY2020 · CA · contact PI
Protein Arginine Methylation in Chemotherapy Resistance$160,001
R01 · FY2020 · CA · contact PI
Protein Arginine Methylation in Breast Cancer$352,820
R01 · FY2019 · CA · contact PI
Protein Arginine Methylation in Chemotherapy Resistance$155,201
R01 · FY2019 · CA · contact PI
Protein Arginine Methylation in Chemotherapy Resistance$160,001
R01 · FY2018 · CA · contact PI
Protein Arginine Methylation in Chemotherapy Resistance$160,001
R01 · FY2017 · CA · contact PI
Targeting Triple Negative Breast Cancer Using Nanoparticles Loaded with the Anti-Cancer Drug Aminoflavone$155,321
R21 · FY2017 · CA · contact PI
Targeting Triple Negative Breast Cancer Using Nanoparticles Loaded with the Anti-Cancer Drug Aminoflavone$182,144
R21 · FY2016 · CA · contact PI
Seahorse XF96e Metabolic Analyzer purchase$159,850
S10 · FY2014 · OD
Transcriptional Regulation of Estrogen Receptor (ER) by CARM1$295,769
R01 · FY2012 · CA · contact PI
Transcriptional Regulation of Estrogen Receptor (ER) by CARM1$60,861
R01 · FY2012 · CA · contact PI
Transcriptional Regulation of Estrogen Receptor (ER) by CARM1$295,769
R01 · FY2011 · CA · contact PI
Transcriptional Regulation of Estrogen Receptor (ER) by CARM1$33,897
R01 · FY2011 · CA · contact PI
Transcriptional Regulation of Estrogen Receptor (ER) by CARM1$304,917
R01 · FY2010 · CA · contact PI
Identification of ERalpha/ERbeta Heterodimer-specific Ligands by HTS$36,754
R03 · FY2010 · MH · contact PI
Transcriptional Regulation of Estrogen Receptor (ER) by CARM1$304,917
R01 · FY2009 · CA · contact PI
Identification of ERalpha/ERbeta Heterodimer-specific Ligands by HTS$37,125
R03 · FY2009 · MH · contact PI
Transcriptional Regulation of Estrogen Receptor (ER) by CARM1$304,917
R01 · FY2008 · CA · contact PI